4/A//SEC Filing
McMullin David 4/A
Accession 0000899243-20-007447
CIK 0001341235other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:42 PM ET
Size
8.0 KB
Accession
0000899243-20-007447
Insider Transaction Report
Form 4/AAmended
McMullin David
SVP Corp. Dev. & Strategy
Transactions
- Award
Common Stock
2020-03-02+247,480→ 255,183 total - Award
Employee Stock Option (Right to Buy)
2020-03-02+250,000→ 250,000 totalExercise: $3.78Exp: 2030-03-01→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2020, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
- [F2]Includes an additional 1,555 shares of common stock previously acquired under the Issuer's Employee Stock Purchase Plan.
- [F3]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2020.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001738662
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:42 PM ET
- Size
- 8.0 KB